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Background: Health care decision makers often need to make decisions in limited timeframes and cannot await
the completion of a full evidence review. Rapid reviews (RRs), utilizing streamlined systematic review methods, are
increasingly being used to synthesize the evidence with a shorter turnaround time. Our primary objective was to
describe the processes and methods used internationally to produce RRs. In addition, we sought to understand the
underlying themes associated with these programs.
Methods: We contacted representatives of international RR programs from a broad realm in health care to gather
information about the methods and processes used to produce RRs. The responses were summarized narratively to
understand the characteristics associated with their processes and methods. The summaries were compared and
contrasted to highlight potential themes and trends related to the different RR programs.
Results: Twenty-nine international RR programs were included in our sample with a broad organizational
representation from academia, government, research institutions, and non-for-profit organizations. Responses revealed
that the main objectives for RRs were to inform decision making with regards to funding health care technologies,
services and policy, and program development. Central themes that influenced the methods used by RR programs, and
report type and dissemination were the imposed turnaround time to complete a report, resources available, the
complexity and sensitivity of the research topics, and permission from the requestor.
Conclusions: Our study confirmed that there is no standard approach to conduct RRs. Differences in processes and
methods across programs may be the result of the novelty of RR methods versus other types of evidence syntheses,
customization of RRs for various decision makers, and definition of ‘rapid’ by organizations, since it impacts both the
timelines and the evidence synthesis methods. Future research should investigate the impact of current RR methods
and reporting to support informed health care decision making, the effects of potential biases that may be introduced
with streamlined methods, and the effectiveness of RR reporting guidelines on transparency.
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Systematic reviews (SRs) are accepted as the gold stand-
ard in evidence-based medicine. Health care decision
makers, however, are increasingly in need of evidence-
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unless otherwise stated.decisions [1]. This has led to the evolution of rapid re-
views (RR), with no common description of their pur-
pose, methods, and format as they vary in time to
completion, report format, literature search strategies,
and methods used for evidence synthesis [1,2]. RR can
be described as evidence syntheses that use methods to
streamline those of SRs to complete the evidence syn-
thesis in a shorter turnaround time [1,3]. Watt et al.
concluded that while RRs are instrumental in answering
specific policy questions, they should not be used to re-
place traditional SRs. Although their comparisons were al. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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views should be ‘fit for purpose’ and tailored to the
knowledge needs of the commissioning body and/or the
intended end users. Further, rapid reviews should not be
viewed as inherently inferior to full systematic reviews
but that more evidence is needed to inform their meth-
odology and application [2]. Furthermore, Watt et al. [2]
found that the overall conclusions did not differ much
between RRs and traditional SRs for similar research ques-
tions. On the other hand, SRs were more likely to incorp-
orate in-depth results on clinical outcomes, economic
considerations, and health service impact. While a stan-
dardized RR methodology may not be considered feasible,
a need for methodological research and increased trans-
parency in reporting has been identified [4].
Decision makers are increasingly seeking evidence to
inform the policymaking process, and this requires ac-
cess to high-quality evidence to inform decisions. As
such, several health care organizations have turned to
abbreviated systematic methods as a means of delivering
evidence in a timely manner. One of the major issues
with RRs, however, is that their methodologies are often
not published or available outside the organization con-
ducting the RR. To date, we have identified two publica-
tions that describe RR programs in detail [3,5], while it
is estimated that conducting RRs is widespread and an
integral part in health care policy and decision making.
Moreover, RRs are not without their challenges. First
and foremost, it is not known how many health care or-
ganizations undertake rapid reviews or what methods
they use. Even less well understood is when to undertake
RRs, whether RRs provide similar results to SRs, and
what potential bias is introduced when abbreviating the
SR review approach.
In September 2013, a group of three health care research
organizations with a shared interest in RRs organized and
facilitated an open ‘Rapid Review Methods Discussion’ at
the 2013 Cochrane Colloquium in Quebec City. Among
the 40 meeting registrants, academia, government, re-
search institutions, not-for-profit organizations, and the
Cochrane Collaboration were represented. The primary
purpose was to exchange and share information between
RR producers and users about the methods used to de-
velop RRs and their usability and appropriateness to sup-
port informed decisions in health care. One of the key
outcomes of this meeting was establishing an informal
network of organizations and researchers interested in
‘rapid reviews’. Further, recognizing the growing need to
better understand the methods used by rapid review pro-
ducers, a number of organizations agreed to share their
processes and methods. The purpose of this study, hence,
was to describe the various RR programs with the aim to
provide an analysis of processes and methods by highlight-
ing themes of characteristics across with these rapidreview programs. Our descriptive analysis represents the
most comprehensive attempt to date to characterize a
broad spectrum of RR programs and their respective
methods. The discussion reflected a wide ranging set of
views on what methods should be maintained and what
can be sacrificed for the sake of timeliness.
Methods
Study sample
Following the rapid review methods discussion meeting
at the 2013 Cochrane Colloquium, we applied purposive
and snowball sampling techniques to form our study
sample. Meeting participants were approached to share
information about the methods and processes used in
their RR programs. Additional RR programs were identi-
fied by the participants and this study’s coauthors. The
Canadian Agency for Drugs and Technologies in Health
(CADTH) led the environmental scan of international
rapid review programs with contributions from the
Ottawa Hospital Research Institute (OHRI) and University
of Manitoba. As CADTH is an independent, not-for-profit
organization funded by Canadian federal and provincial
governments, we are not required to seek ethics approval
to obtain information from various organizations about
their practices and methods on a specific health care topic.
In our correspondence with the organization, we indicated
a priori that any information provided will be used in a
publication, so consent to publish was not needed as the
feedback was provided on a voluntary basis.
Data collection
A form was developed and organized into nine domains
to collect information specific to methods and processes
by the identified program (Table S1 in Additional file 1).
The participants were asked to provide details about
their program’s definition of RR, report types produced
by their program, details regarding topic selection, edu-
cation sessions with client or funder, protocol develop-
ment, report production, submission and dissemination,
if the report becomes publicly available and if there was
a website for their RR program. Details for the following
RR programs were pre-populated to illustrate the types
of responses requested from the participants: the
CADTH, Oregon Health Sciences University, and OHRI.
Data analysis
Results were collected on a voluntary basis and collated
in an electronic database for review, quality assurance,
and analysis. The unit of analysis was the RR program
and not the type of RR produced as some programs pro-
vide a range of RR services. We calculated the frequen-
cies of responses for questions with predefined answers.
For the remaining questions, we listed program re-
sponses as there was potential for misinterpretation
Polisena et al. Systematic Reviews  (2015) 4:26 Page 3 of 7given the array of answers. The characteristics associated
with the processes and methods for the RR programs in
our sample were summarized narratively according to
their responses. Subsequently, we compared and inter-
preted the results to identify the underlying themes and
patterns from the RR program descriptions.
Results
Countries of origin
Twenty-nine RR programs were included in our sample.
Twelve RR programs were based in Canada, five from
the USA, three each from Australia and UK, two each
from Germany and Finland, and one each from Italy and
Taiwan. Our sample included broad organizational rep-
resentation from academia, government, research insti-
tutions, and non-for-profits.
Rapid review definition
Our responses revealed that there was no standard defin-
ition for RR. Definitions were organized into six categories
based on the descriptions provided. They are as follows:
accelerated, condensed, focused, type of evidence synthe-
sis, modified systematic review, and tailored. Individual re-
sponses are presented in Table S2 in Additional file 2.
Purpose of rapid review report
Responses from the participants indicated that the pri-
mary objectives to produce RRs were to inform decision
making with regards to funding health care technologies,
services, and policy and program development. Some
decision makers requested evidence for clinical decision
making, implementation, clinical and operational effect-
iveness, and efficiency. In addition, these reviews were
reported to be used to complement discussions between
health service staff and manufacturers and to improve
the understanding of a specific topic based on the pub-
lished evidence.
Types of report produced by rapid review programs
There was a wide array of RR report types in our sample
(Table S3 in Additional file 3). Report types can range
from a simple annotated bibliography to a rigorous
health technology assessment (HTA) of a single health
technology. The full spectrum included reference lists,
summaries of abstracts, reviews of reviews, rapid system-
atic reviews, systematic reviews and meta-analyses, and
single HTA. Several organizations produce more than
one type of RR.
Processes
Development of protocol
Most RR programs (n = 28; 96.6%) incorporated protocol
development as part of the RR process; one respondent
did not indicate if a protocol is used or not. Componentsspecified in a protocol centered mainly on patient popu-
lation(s), intervention(s), comparator(s), outcome(s) and
study design(s), and the research question(s). Fifteen RR
programs (51.7%) prepared protocols in conjunction
with the requestor.
Review process of draft report
Twenty-four RR programs (82.8%) reported conducting
internal reviews of the draft RR and a subset of programs
(n = 13; 44.8%) also had drafted RRs reviewed externally.
Seven respondents (24.1%) stated that a decision to carry
an external review depended on the type of RR report and
timeline for completion, and additionally only if requested.
In two instances, it was reported that the requestor regu-
larly reviewed the draft report before being finalized. In-
formation from industry was generally not sought, with
only a handful of respondents indicating that they do this
on a regular basis (n = 4; 13.8%) or on a case-by-case basis
(n = 3; 10.3%).
Report template
Based on responses from our sample, elements consistently
incorporated in a RR based on the study sample are key
messages or recommendations to support dissemination
(n = 28; 96.6%), context and policy issues/implications of
the synthesized evidence (n = 26; 89.7%), references to
review methods used (n = 26; 89.7%), and an explanation
of the strengths and limitations of review methods used
(n = 26; 89.7%). Some RR producers also included tables
(n = 18; 62.1%), graphs (n = 15; 51.7%), and a legal dis-
claimer (n = 12; 41.4%) in the final report.
Turnaround time for final report
The turnaround time to produce a RR ranged from 1
week to 12 months; median was 3 months. The time-
frame is reflective of the differing interpretation of
‘rapid’ to various organizations. Although we did not
cross reference each report type with the turnaround
time for report completion, we can assume that the
length of time was dependent on the complexity of the
research topic, analyses required to synthesize the evi-
dence, and types of reports produced.
Rapid review dissemination
Twenty RR producers (69.0%) disseminated their report
beyond the requestor, while five (17.2%) responded that
dissemination depends on the sensitivity of the topic
and/or permission from the requestor. In addition, 11
RR producers (37.9%) posted the full rapid review on the
Internet, with one additional producer reporting just
posting a summary of the report. Three respondents in-
dicated that the Web posting of their RR depended on
the type of report produced and/or if permission was
granted by the requestor. Table S3 in Additional file 3
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ate their reports to a wider audience. Common examples
include stakeholder meetings or workshops, presenta-
tions at academic or policy conferences and forums, the
use of social media (e.g., Twitter and RSS) and video
summaries, webinars, publication in peer-reviewed jour-
nals, online review summary databases and newsletters,
email distributions, and preparation of summaries and
other supporting materials.
Methods used
Types of research questions
For many programs, requestors sought evidence on clin-
ical effectiveness (n = 16; 55.2%), clinical efficacy (n = 12;
41.4%), cost-effectiveness and/or cost savings (n = 12;
41.4%), safety (n = 9; 31.0%), and to support clinical prac-
tice guideline preparation (n = 5; 17.2%) for either a
health care technology or service. Nine respondents
(31.0%) also stated that research questions focused on
the accuracy of diagnostic or screening tests. Some RR
programs focused exclusively on questions centered on
health care policy, coverage of a technology, health sys-
tem interventions, health services delivery, operational
efficiency, and quality improvement. Two organizations
(6.9%) focused on specific health topics. More specific-
ally, one RR program focused exclusively on questions
related to HIV/AIDS and other sexually transmitted and
blood borne infections, and another focused on topics
related to public health programs. One RR program in
Canada was focused on health and social science topics
associated with suicide prevention, conceptions of mas-
culinity, obesity, and musculoskeletal injuries.
Literature search strategy
All RR programs incorporated multiple databases and
websites as data sources for their reports. Commonly
searched databases included PubMed/MEDLINE,
CINAHL, Embase, PsycINFO, Cochrane Library, and
University of York’s Centre for Reviews and Dissemin-
ation and TRIP databases. In our study, grey literature
was defined as literature that is not commercially avail-
able or indexed by major databases. Fourteen RR pro-
ducers (48.3%) reported consistently searching trial
registries and medical society, government regulatory,
and health technology assessment websites for relevant
grey literature (Table S4 in Additional file 4). Twelve RR
producers (41.3%) searched systematic reviews and pri-
mary studies, while 11 programs (37.9%) expanded
their search strategy to incorporate primary studies if
no systematic reviews were found and one (3.5%)
searched primary studies if the SRs were published 2
years ago or more. Three RR programs (10.3%) did not
search for primary studies, and two (6.9%) did not indi-
cate if they searched primary studies. The searchtimeframe varied among producers from 5 (n = 5;
17.2%) to 10 years (n = 4; 13.8%), one producer noted
searching from the year 2000 onwards. Eight partici-
pants (27.6%) responded that the time period searched
was based on the topic. Literature search strategies
were not peer-reviewed among 14 RR producers
(48.3%), and four respondents (13.8%) indicated that it
was conducted depending on the report complexity and
funding available. Language restrictions were imposed
by the majority of RR producers in our study, where
English only studies (n = 17; 58.6%) or studies published
in English and another language (n = 5; 17.2%) were
searched. Seven respondents (24.1%) did not specify
whether they used language restrictions as part of their
search strategy.
Study selection and data abstraction
Numerous RR programs in our sample used two re-
viewers to select studies for inclusion (n = 16; 55.2%)
and for data abstraction (n = 14; 48.3%). A few respon-
dents stated that the number of reviewers for the study
selection (n = 2; 6.90%) and data abstraction (n = 3;
10.3%) was predicated on the research topic.
Evidence synthesis
A narrative summary was the most common method
used to synthesize the evidence (n = 27; 93.1%), while
four (13.8%) reported regularly conducting a meta-
analysis and three producers (10.3%) include economic
evaluations in their reports. The appropriateness of a
meta-analysis in a RR would partially depend on the
type of report produced. Two RR programs (6.9%) did
not specify the type of evidence synthesis conducted. A
few RR programs occasionally performed meta-analyses
(n = 5; 17.2%) or syntheses of the economic literature
(n = 4; 13.9%).
Critical appraisal
Most RR producers (n = 20; 69.0%) indicated that they
critically appraised the selected studies in their reports,
while two (6.90%) did it depending on the report type
and time permitted. Seven RR programs (24.1%) do not
conduct a critical appraisal of studies. Similar to other
forms of evidence synthesis or HTA, validated critical
appraisal tools were selected according to their appro-
priateness for the study design (Table S4 in Additional
file 4).
Interpretation
Based on a sample of 29 RR programs, the study find-
ings revealed that the definition of, and methods to con-
duct, RRs was more fluid and flexible compared with
those established for a traditional systematic review or
HTA. This phenomenon can be related in part to the
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proaches, tailoring of RRs to meet the decision makers’
needs, and how an organization defines ‘rapid’ since the
definition impacts both the timelines and the conduct of
the evidence synthesis. Central themes to factors that
appear to influence the methods used by RR programs
and their respective report types and dissemination are
the imposed turnaround time to complete a report; re-
sources available; the complexity and sensitivity of the
research topics; and permission from the requestor.
From the responses we received, it is evident that a ‘one-
size fits all’ approach may not be appropriate as RRs are
produced for decision makers in an array of health care
areas for different purposes and with diffing available
resources and time constraints. It, therefore, seems chal-
lenging to develop a formulaic process or methodology
that would be endorsed by all RR producers and users.
Even so, further research may reveal particular common
points of interest that would allow some standardization
of the methods used to conduct specific types of RR and
how to best report their results.
Discussion
Although our sample was not exhaustive, we sought to
identify and synthesize the processes and methods used
by RR programs throughout the world. Overall, our
results were consistent with the findings of previous re-
views on methods used to produce RRs [2,6]. A review
of 49 RRs located in the HTA database of the Cochrane
Library and six international HTA databases from 2000
onwards found many differences in literature search
strategies, quality assessment, data extraction, synthesis
methods, report structure, and number of reviewers con-
ducting the RR [6]. The authors also reported a positive
correlation between the length of time to produce a RR
and the application of standard SR reporting methods.
In another study, Watt et al. [2] surveyed 23 HTA pro-
ducers (response rate = 46%) on their practices in pre-
paring RRs. Similar to our study results, the authors did
not observe any consistent trends associated with the
contents, methods, and definition of a RR. Subsequently,
they concluded that while it may not be possible to
standardize RR methods, HTA producers should in-
crease the transparency of the methods used in each
review.
RR producers are faced with a conundrum, having to
meet the time-sensitive needs of decision makers, while
at the same time attempting to maintain methodological
rigor. This challenge has led different research groups to
routinely short-cut different aspects of the traditional re-
view methods in order to complete the evidence synthe-
sis in the allotted time. It is understood that the
streamlined methods used to produce RRs can inadvert-
ently introduce bias into the review process. Thecomprehensiveness of a RR can be reduced if the litera-
ture search strategy incorporates an insufficient number
of databases and languages, searches for publications are
conducted within shortened timeframes and excludes
the grey literature; resulting in an increased risk of miss-
ing publications of relevancy. Although potential biases
in RRs have not been empirically studied, potential
sources relate to the study selection and data extraction
by one reviewer. As found in both our study and noted
by Watt et al. [2], RR methods can omit external peer-
review by content or methodological experts of the draft
report. In instances where a quality assessment of stud-
ies is not performed, decision makers are left to deter-
mine if the study results are valid or are to be
interpreted with caution. Since it is becoming more
common to use RRs to support health care decision
making, there has been growing interest in exploring
further methods research within this realm. One avenue
under consideration is the establishment of a Cochrane
Rapid Reviews Methods Group. The primary function of
this group would be to initially serve as a forum for dis-
cussion, and information sharing with regards to RR
methods across the collaboration and beyond. The ideal
aim will be to further investigate whether potential
biases are inherent in RRs.
RRs may be used to inform specific health care deci-
sions in a timely manner using relevant evidence, but
their appropriateness in health care and HTA merits fur-
ther investigation [2]. Legal implications associated with
the use of RRs for decision making also must be consid-
ered [1-4,7]. Although previous studies reported that the
majority of RRs focused on the clinical effectiveness and
efficacy of a heath care technology or an intervention,
12 RR producers in our sample also incorporated evi-
dence on cost-effectiveness and/or cost-savings. This
may reflect an evolution of RR methods as well as the
economic considerations incorporated more frequently
in health care decisions. As reported in the previous
studies, most RR programs did not mention discussions
regarding the impact of their reviews on health services,
such as ethical, legal, and psychosocial implications.
Limitations
Interpretation and application of the findings of this
study may be influenced by several limitations. Twelve
of the 29 RR programs were based in Canada, and over
70% represented English-speaking jurisdictions. Our re-
spondents, however, represented a cross section of RR
programs in existence for health care decision making
today. In addition, purposive sampling was employed, so
the participants were not randomly selected. To help
strive for comprehensiveness in our sample, RR pro-
grams from four continents, at various levels in the
health care systems with diverse foci in across health
Polisena et al. Systematic Reviews  (2015) 4:26 Page 6 of 7sectors provided data. An additional limitation was that
we were unable to distinguish any patterns between the
purpose of the RR and the methods applied to produce a
report. Although we inquired about the types of research
questions addressed in a RR, we were unable to assess
their scope according to the responses provided. Further,
we were unable to explain potential reasons and causes
for differences across the programs based on the infor-
mation collected. This warrants further investigation.
Directions for future research
Based on discussions at the Cochrane 2013 Colloquium
meeting and by having taken a more in-depth look at
the methods employed by the network members, vari-
ous organizations employ different measures for their
program. The impact of a RR used to inform health
care decisions remains unknown as few programs have
measured it. Impact measurement, although compli-
cated, should be encouraged. It would be important to
capture metrics related to, for example, how often the
report was used to inform a decision, policy or debate;
cost savings; harms reduction; and/or how often, and in
what manner it was portrayed in the media. The results
of our analysis highlight the reality that RR products
provide flexibility and are time sensitive. Methodo-
logical research should be undertaken to develop tax-
onomy of types of RRs and understand the strengths
and limitations of the various forms of RRs in keeping
with the volume and type of evidence identified, as well
as the level of synthesis performed. How the findings
are reported may impact health care decisions and un-
derstanding the extent of bias [8]. Future research also
can explore the methods used across a wide range of
RRs produced by various organizations to assess how
they align with the Preferred Reporting Items for Sys-
tematic Reviews and Meta-Analyses (PRISMA) guide-
lines and a measurement tool to assess systematic
reviews (AMSTAR). This research will be undertaken
by one of our coauthors, who is pursuing funding to
assess a large sample of RRs from a variety of organiza-
tions, as part of her doctoral studies. The findings will
provide some insight on the similarities and differences
between a RR and a traditional SR to allow for a better
understanding on the production of a RR in a shorter
turnaround time and with fewer resources, as well to
the extent a SR may be of merit. In addition, future
studies should investigate potential trends of RR pro-
grams according to numerous characteristics, such as
geography, organization type, and target audience.
Moreover, a qualitative research study of evidence-
based health researchers, including RR producers and
health care decision makers, should investigate the
feasibility and desire for an extension to the PRISMA
guidelines to incorporate RR methodologies [9]. At aminimum, reporting guidelines can increase the trans-
parency of RRs.Conclusions
The processes and methods for 29 international RR
programs were reviewed and compared for greater
insight on the different forms of RRs. Although numer-
ous RRs focus on questions of clinical effectiveness, ef-
ficacy and cost-effectiveness, there is no single cohesive
method to conduct a RR. In addition to the turnaround
time, the resources available, the complexity and sensi-
tivity of the research topics, and permission from the
decision maker have an impact on the types of RR pro-
duced and their dissemination. Future studies should
evaluate the appropriateness of the different RR
methods and reporting for health care decisions, how
the methods used across an array of RRs align with the
PRISMA guidelines and AMSTAR tool, and the rele-
vance of reporting guidelines for RRs to improve their
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